University of Queensland
Professor Scott Bell MBBS, MD, FRACP is the Chief Executive of the Translational Research Institute and a Senior Physician of the Adult Cystic Fibrosis Centre at The Prince Charles Hospital where he has worked since 1996 in Brisbane. He was Director between 1996-2015. As a clinician scientist, he leads the Lung Bacteria Laboratory at UQ. Scott has >300 peer reviewed publications and has received grant support >$24 million. His research interests include acquisition and transmission pathways for human infection and his multi-disciplinary research has resulted in significant changes to clinical practice and policy implementation globally. He has been principal investigator on numerous pivotal CFTR modulator trials. He was the Editor of the Journal of Cystic Fibrosis from 2013 until 2020 and co-led the Lancet Commission on the future of CF care which was published in 2020.
S11.1- The Final Frontier for All PwCF: NABTs from the Investigator & Community Perspective
Thursday, September 26, 2024
2:30 PM – 4:30 PM ET